i good fortune read journal clinical psychiatry supplement featured dr henry nasrallah author sneaking friendly messages ziprasidone gedon antipsychotic pfizer dwarfed competitors zyprexa seroquel risperdal piece discusses findings catie study compared several newer antipsychotics older medication perphenazine generally found newer older drugs roughly equal effectiveness olanzapine worst safety profile i thank alert reader passing article along cme overview good news physicians read article take quiz part continuing medical education cme helps maintain licenses bad news articles often thinly veiled advertisements product message supports product highlights stated difference favoring olanzapine zyprexa ziprasidone terms efficacy significant statistical adjustment granted seems like legitimate argument mentions olanzapine worst metabolic profile terms effects weight blood glucose glycosylated hemoglobin cholesterol triglycerides states contrast patients treated ziprasidone best overall metabolic profile places numbers table regarding metabolic effects various drugs catie study provides single statistical analysis reference analysis catie data backing assertion significantly better drugs terms metabolic profile piece turns secondary phase catie study patients discontinued medications first phase catie assigned medications mentions olanzapine weight gain mentions patients ziprasidone lost weight discusses weight loss ziprasidone moves ziprasidone associated decreases cholesterol triglycerides whereas olanzapine associated gains measures case readers sleep reading piece moves state except clozapine olanzapine clearly caused heaviest burden metabolic side effects ziprasidone hand consistently associated benign side effect profile piece moves scare reader older antipsychotics risk inducing extrapyramidal symptoms eps clinician must carefully decide whether lower cost typical antipsychotic worth potential striatal neurotoxicity manifested acute extrapyramidal side effects long term td tardive dyskinesia course must assuming atypical antipsychotics never rarely induce eps appears wrong older medications induce eps rate haldol likewise incorrect overall message bottom line message piece clear geodon safe zyprexa unsafe use older meds cause eps ziprasidone fact geodon safest second generation antipsychotics take test done infomercial er article physician needs fill enclosed test open book test i imagine everyone passes mail physicians even complete test online section taken directly earlier post ghostwriter watch wrote article tell me i confused written article article derived planning teleconference evaluating evidence clinical antipsychotic trials intervention effectiveness catie beyond held may independently developed cme institute physicians postgraduate press inc health wellness education partners hwep pursuant educational grant pfizer addition support hwp publishing dr nasrallah consultant received honoraria speakers advisory boards abbott astrazeneca janssen pfizer shire received grant research support astrazeneca janssen pfizer content development writing support article provided part independent writer contracted hwep martin korn psychiatrist private practice new york i may piecing together wrong goes pfizer writes check cme institute hwep nasrallah bigwigs engage conference call reimbursed likely quite well time hwep hires martin korn write piece reviewed likely cursory manner dr nasrallah piece reviewed member cme advisory board reviews appear consist race grab rubber stamp quickly possible i sure pfizer provided talking points directly dr korn seems got message zyprexa older meds slammed geodon come across looking angelic cme institute stamps approval call assured doctors educated latest greatest treatments purely objective fashion please also feel free read earlier piece cme i recall seeing dr korn name earlier cme piece similar i ca seem track confused i defending zyprexa geodon appears safer drug zyprexa quite thinly veiled advertisement masquerades independent education ludicrous reading watching commercials passing education help physicians make better decisions patients